The protocols described by McCafferty and Johnson (1996) were followed for generation and testing of 3 large scFv pools with the modifications specified in Fraile et al. (2001) . Briefly, the spleens of inoculated 4 mice were processed for extraction of mRNA following the guanidinium isothiocyanate-acid phenol 5 procedure (Ultraspec™ RNA isolation, Biotecx). The poly-A + mRNA was purified using an oligo-T resin 6 (OligoTex™ kit, Qiagen) and then employed as template for a first-strand cDNA synthesis reaction (GE 7 Amersham). The VH and VL gene segments were amplified from the cDNA samples using the primers 8 indicated in (Fraile et al., 2001) . The scFv-genes were then joined in a VH-linker-VH configuration. After 9 amplification, the ~0.7 kb DNA fragments corresponding to the assembled scFvs were digested with SfiI
10
and NotI restriction enzymes, gel-purified, and ligated into the same sites of pCANTAB-5Ehis (Fernandez 11 et al., 2000) in such a way that the scFvs sequences become tagged with a an E-tag epitope and Assembling the library of M13 particles displaying scFv-protein III hybrids (Phab production) was done as 20 described in (Fraile et al., 2001 ) and sketched in Fig. 1 Plasmid pPC2 was transformed into the non-suppressor E. coli strain HB2151. 250 ml of LB, containing Tyr172, Asp175 and to a lesser extent, Leu177 (marked with an asterisk). The residues more important for mutual recognition are marked with an asterisk at the bottom.
